Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Renal Pelvis and Ureter Urothelial Carcinoma × infigratinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 2 Cholangiocarcinoma 2 Upper Tract Urothelial Carcinomas 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Glioma 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

infigratinib 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04228042 2025-01-01

Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer

M.D. Anderson Cancer Center

Phase 1/2 Terminated

15 enrolled 10 charts

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡